Polysomnographic Findings in Nasal Polyposis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Lille

About this trial

Nasal polyposis (NP) is a chronic inflammatory disease of the nasal and sinus mucosa leading to protrusion of edematous polyps in the nasal cavity. Prevalence of NP among the chronic rhinosinusitis patients is 25-30 %. NP leads to significant limitations in physical, emotional and social aspects of life of the affected patients. Sleep disorder is frequently reported by those patients with impaired nasal breathing. Till now few studies have objectively assessed the impact of NP on sleep quality. the objectives are to figure out sleep disturbances in NP and to analyze the outcomes of sinus surgery on sleep recovering.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who underwent endoscopic sinus surgery for recalcitrant nasal polyposis (failure of a 4-month corticosteroid medical treatment) Social insured patient

Patient willing to comply with all procedures of the study and its duration

Patient giving consent

Disqualifiers

Patients with previous nasal surgery for nasal polyposis

Patients with previous continuous positive airway pressure therapy for obstructive sleep apnea

Non-coverage by the social security scheme

Patient unable to receive informed information

Trial design

Design model

Single group

Treatments tested in this trial

  • Endoscopic sinus surgery

    Procedure/Surgery

    Surgical procedure under general anaesthesia: Consists of the removal of bone boundaries between sinus cavities (ethmoidectomy) with nasal polyps resection in order to retrieve nasal patency and sinus drainage Polysomnographic assessment as routinely applied in clinical practice

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: endoscopic sinus surgeryExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Slow-wave sleep duration

Slow-wave sleep duration is measured one month before surgery and 3 months after surgery

Time frame
1 month before surgery and 3 months postoperatively

Secondary outcomes

1

change in total sleep duration

duration in min of total sleep at each endpoint

Time frame
At 1 month before surgery and at 3 months postoperatively
2

Change in the number of brief wakefulness

comparison of the number of wakefulness between visits

Time frame
At 1 month before surgery and at 3 months postoperatively
3

change in Apnea-hypopnea index

This index measures the number of apnea and hypopnea during the total sleep duration.

Time frame
At 1 month before surgery and at 3 months postoperatively
4

Change in time with oxygen desaturation below 90%

desaturation before anf after surgery measured

Time frame
At 1 month before surgery and at 3 months postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.